VBIO (Valion Bio) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VBIO Valion Bio Inc VBIO
22 GF Score
Price $3.03
! 4 Warning Signs
View Full Analysis

What is Valion Bio Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

VBIO
22GF Score
Valion Bio Inc VBIO
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valion Bio Business Description

Address 1305 East Houston Street, Suite 311, Building 1, San Antonio, TX, USA, 78205
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
22GF Score

Get the complete analysis for VBIO

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.03
Price